NRx Pharmaceuticals Inc. (NASDAQ: NRXP) In 2022: Will It Be Worth Investing In?

view original post

In the last trading session, 1.0 million shares of the NRx Pharmaceuticals Inc. (NASDAQ:NRXP) were traded, and its beta was 0.33. Most recently the company’s share price was $4.78, and it changed around -$0.18 or -3.63% from the last close, which brings the market valuation of the company to $291.15M. NRXP currently trades at a discount to its 52-week high of $64.20, offering almost -1243.1% off that amount. The share price’s 52-week low was $4.07, which indicates that the current value has risen by an impressive 14.85% since then. We note from NRx Pharmaceuticals Inc.’s average daily trading volume that its 10-day average is 1.86 million shares, with the 3-month average coming to 4.41 million.

Instantly NRXP has showed a red trend with a performance of -3.63% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.20 on Friday, 12/31/21 increased the stock’s daily price by 8.08%. The company’s shares are currently down -80.41% year-to-date, but still down -5.16% over the last five days. On the other hand, NRx Pharmaceuticals Inc. (NASDAQ:NRXP) is -19.53% down in the 30-day period. We can see from the shorts that 1.92 million shares have been sold at a short interest cover period of 0.31 day(s).

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


NRx Pharmaceuticals Inc. (NRXP) estimates and forecasts

NRXP Dividends

NRx Pharmaceuticals Inc.’s next quarterly earnings report is expected to be released in February.

NRx Pharmaceuticals Inc. (NASDAQ:NRXP)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 59.40% of NRx Pharmaceuticals Inc. shares, and 3.62% of them are in the hands of institutional investors. The stock currently has a share float of 8.91%. NRx Pharmaceuticals Inc. stock is held by 28 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Sep 29, 2021, it held 1.70% of the shares, which is about 1.0 million shares worth $9.27 million.

Cambridge Investment Research Advisors Inc., with 0.26% or 0.15 million shares worth $1.42 million as of Sep 29, 2021, holds the second largest percentage of outstanding shares.

>> 7 Top Picks for the Post-Pandemic Economy <<

Vanguard Total Stock Market Index Fund and Fidelity NASDAQ Composite Index ETF were the top two Mutual Funds as of Sep 29, 2021. The former held 0.96 million shares worth $8.86 million, making up 1.62% of all outstanding shares. On the other hand, Fidelity NASDAQ Composite Index ETF held roughly 40599.0 shares worth around $0.41 million, which represents about 0.07% of the total shares outstanding.